|
Laws regulating Diet Drugs define the responsibility and / or
liability of anyone with a responsibility for a diet product -- from the
supplier or manufacturer to the seller -- if that product causes damage due to
defect. Physicians may also be found liable if the diet drug in question
is a prescription product and the guidelines regulating its use and monitoring
were not followed. These instances would generally be a failure to provide
reasonable professional standards for the practice of medicine and would be
considered medical
negligence or malpractice.
Product liability
laws allow liability claims based on negligence, strict liability, or breach
of warranty of fitness for a particular purpose. The United States
Department of Commerce has promulgated a Model Uniform Products Liability Act (MUPLA)
for voluntary use by the states.
There are no federal product's liability laws and yet most diet drugs are
tested and released for prescription by American physicians under the Federal
Food and Drug Agency (FDA). Testing of diet drugs is commonly inadequate.
Examples of product liabilities in diet drugs involve defective products such
as drugs appearing on the market with improper labeling and lack of quality
control in the producing of such drugs as well as products that do not live up
to their respective guarantees or warranties. A product is legally considered
defective if it was made poorly or sold with flaws. A diet drug may commonly
fulfill its purpose as expected but normal use may cause discomfort, injury or
even death. A diet drug may also be safe if used carefully, but it may be
considered defective if the manufacturer 's information on proper dosage or
proper monitoring is unclear, incomplete or incorrect. This misrepresentation
concerning the product, if resulting in an injury, may entitle the plaintiff to
damages.
Recent years have seen many recalls of hastily approved diet drugs. Scheduled
to be prescribed for blood sugar control in patients with type 2 diabetes
mellitus- (non-insulin dependent diabetes), these defective products are
responsible for scarring, pain, suffering, disabilities, loss of income, debt
due to medical and other bills and even death. Unfortunately, the very
patients who are receiving these prescriptions may be least likely to tolerate
them.
- In July of 1997, the FDA requested that fen-phen,
and derivations of fen-phen, also known as redux, be recalled
after reports of neurological damage or heart failure.
- Ephedra or Ma Huang is a diet supplement (not
regulated by the FDA). The FDA is now calling for limits on recommended
dosages and proposing new consumer notice (labeling) requirements due to
reports of heart attack, seizure, stokes, hemorrhage, high blood pressure,
rapid or irregular heart rate, or death.
- In March 2000, Rezulin®,
also known as Actos, or Avandia, was recalled in the United States
due to liver toxicity and reports of heart damage.
- PPA or Phenylpropanolamine is used in numerous diet pills,
such as Dexatrim and Accutrim. The FDA is investigating a ban on the
use of PPA in prescription and nonprescription drugs. PPA may be responsible
for several hundred hemorrhagic strokes suffered by people under the age of
50.
- On Tuesday, March 19, 2002, Public Citizen, a consumer group, petitioned
the FDA to pull Meridia off the market in the United States. Meridia,
also known as Sibutramine or Reductil, was called
"unacceptably dangerous" after reports began to be received of
liver failure and deaths. (Some European countries have suspended
sales of Meridia.)
Many patients in need of weight reduction due to other serious and possibly
life threatening medical conditions, have also been prescribed other drugs which
interact with these diet drugs in dangerous ways. A majority of patients
with Type 2 Diabetes also have hypertension (high blood pressure) and other
disorders. Medications for hypertension, Parkinson's disease, depression -
even medications over the counter for allergies and colds - have been shown to
dangerously increase medical risks of cardiac problems (including heart
failure), liver problems (including extensive damage requiring a transplant of
the liver and liver failure), eye damage, inability of blood to clot, bruising,
neurological complications and seizures.
Products' liability laws are designed primarily to prevent harm or to
compensate a person or property for harm. The harm or injury caused by
diet drugs is most often a physical injury and/or financial injury. These
laws are generally grouped under the same category as Personal Injury Law, which
is tort law.
A civil wrong, known as a tort, is recognized by law as grounds for a
lawsuit. Sometimes these wrongs are considered crimes and punishable by
imprisonment, but the primary aim of tort law is to provide relief through
compensation to injured parties for the damages they have incurred. Among
the types of recoverable damages are: loss of earnings capacity, pain and
suffering, and reasonable medical expenses. They include both present and
future expected losses. This means that a person who has been injured due to a
defect in a product or a breach of an expressed or implied warranty may be able
to bring a lawsuit against the manufacturer or the seller, or anyone else in
between.
Wrongful Death is
a very real possibility when diet drugs are taken improperly or not monitored
properly and the end result is death. In these instances the law provides
for compensation to the victim's heirs or estate.
Torts occur through unreasonable negligence, malicious intention or strict
liability. Tort law is state law created through state courts and
generally using the Restatement of Torts (2nd) as an influential guide.
Product Liability
American National Standards Institute (ANSI)
Consumer Information Center
Consumer Product Safety Commission
Injury Statistics Query and
Reporting System
Injury Statistics Query and
Reporting System
Kids In Danger
National Toxicology Program
Products Liability
Product Safety
Research - Standards and Specifications
Tobacco Industry
Documents
Toxic Torts
U.S. Consumer Gateway:
Product Safety
Vehicle Recall
Information from the Consumer Product Safety Commission
Product Liability Federal Statutes
Magnuson - Moss
Warranty Act (Consumer Product Warranties), 15 U.S.C. §§ 2301 et seq.
Product Liability Federal Judicial Decisions
U.S. Supreme Court: Recent
Products Liability Decisions
U.S. Circuit Courts of Appeals: Recent
Products Liability Decisions
Product Liability State Statutes
Uniform Laws
State Statutes
State Judicial Decisions
Drugs / Pharmaceuticals
- Baycol
(Cerivastatin) Information - from the FDA.
- Baycol
FDA.com - informational news service helping those affected by
Baycol and rhabdomyolysis.
- Bayer Voluntarily Withdraws Baycol
- Biology
of the Kidneys and Urinary Tract
- CNN.com - Bayer: Baycol anti-cholesterol drug linked to ...
- Kidney
Failure
- DES
- DES Action USA
- The DES Cancer Network
- Diabetes
- Rezulin
- Avandia
- Enbrel
- Important
Drug Warning - Enbrel
- Federal Health
Agencies
- Fen-Phen
- The
New England Journal of Medicine
- Fen-Phen,
obesity, and fitness issues
- Fen-Phen Chat
room
- Fighting for
Victims of Fen-Phen
- Fen-Phen
Frequently Asked Questions
- Public
Citizen Press Release To Recall Meridia
- AP
Wire | 03/19/2002 | Group Asks FDA to Pull Diet Drug
- U.S.
Food and Drug Administration (FDA)
- FDA
APPROVES SIBUTRAMINE TO TREAT OBESITY
- Phenylpropanolamine
(PPA) Information Page
- Public
Citizen | Drug Information Center - Drug Information
- Meridia home page
- Meridia
FAQ: For Patients
- Medical Products
Liability and Recalls
- Pharmapages
By the publisher of Scrip World Pharmaceutical News. Covering internet and
technology issues in the pharmaceutical industry, articles on regulatory
affairs, research and development and technology developments listings of
new pharmaceutical websites, virus news, conference listings, and a glossary
of terms
- Propulsid Cisapride
Information
- Prozac
- Prozac
murder-suicide coming before a federal court judge
- Fighting for
Victims of Prozac & Fen-Phen
- Kids,
Drugs, Guns and Psychopolitics
- Propulsid Information
Cisapride
- Raxar
- Raxar
- FDA
- Registration
for Medscape
First time users must register - free
- Researching Medical
Literature on the Web
Article providing medical research links and an explanation of what each
site offers
- Rezulin
- Clinical
Manifestations of Liver Disease
- Diagnostic
Tests for Liver and Gallbladder Disorders
- FDA
press release - withdrawing Rezulin
- Fatty
Liver, Cirrhosis, and Related Disorders
- Lifeclinic
Diabetes Center
- Signs
and Symptoms of Liver Cancer
- Symptoms
of Hepatitis
- Rezulin Information
- Avandia - Similar
Diabetes Drug
- RxList-The Internet Drug Index
Tort Law Federal Statutes
Tort Law Federal Judicial Decisions
U.S. Supreme Court: Recent
Torts Law Decisions
U.S. Circuit Courts of Appeals: Recent
Torts Law Decisions
Tort Law State Statutes
State Judicial Decisions
N.Y. Court of Appeals:
Federal Statutes Damages References
U.S. Code:
15 U.S.C. §§
15-15e - Restraint of Trade Suits
26 U.S.C. -
Damages and Income Taxation
28
U.S.C. - Recovery of Damages Against the U.S. and Foreign States
45 U.S.C., Chapter 2
- Railway Carriers
Federal Court Rules and Judicial Decisions - Damages
Federal Rules of Civil Procedure:
Rule 9(g)
- Special Damages
Rule
54(c) - Judgment
U.S. Supreme Court: Recent
Decisions Dealing with Damages
U.S. Circuit Courts of Appeals: Recent
Decisions Dealing with Damages
Damages State Statutes
Uniform Laws
U.C.C.,
Article 2, Part 7 - Remedies
State Statutes
Article 2 of
Uniform Commercial Code as Adopted by Particular States
State Judicial Decisions
N.Y. Court of Appeals:
Appellate Decisions from Other
States
Back to Top
© 2001-
2006 2002 Consultwebs.com. All rights reserved. Information in this document
is subject to change without notice. No representation is made regarding
accuracy or quality of linked sites.
The use of Frames without acknowledging the page identity and authors is
prohibited
Web site by Consultwebs.com
Back to Top
|